SBLENDORIO GLENN (President and CEO) sold 7.1% of their position (17.45K shares) of IVERIC BIO, INC. on the open market
Open‑market sale worth $350.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/4/2023ACC: 0001410939-23-000008
DirectorOfficer· President and CEO
Since Dec 2018
-17.45K
Net shares
Net seller
$350.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
31.50K acquired · 48.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+31.50K
Price / share
—
Trade value
—
% of position
14.7%
1/2/2023
214.14K→245.64K
Common Stock
Direct
Shares
−17.45K
Price / share
$20.06
Trade value
$349.99K
% of position
7.1%
1/3/2023
245.64K→228.19K
Total
Net shares
+14.05K
Net value
-$349.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2023 | M · Option Exercise | +31.50K | — | — | 14.7% | 214.14K | 245.64K |
| Common Stock Direct | 1/3/2023 | S · Sale | −17.45K | $20.06 | $349.99K | 7.1% | 245.64K | 228.19K |
| Total | +14.05K | -$349.99K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
31.50K shares
Shares
−31.50K
Strike price
Held after
94.50K
Exercisable
—
1/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock31.50K shares | 1/2/2023 | M · Option Exercise | −31.50K | — | 94.50K |